Sharon Griffin

Sharon Griffin resolves the legal and litigation issues airing from MBM's patent, trademark, industrial design, and copyright practice. She is an advocate before the Federal Court, the Federal Court of Appeal, the Ontario Superior Court of Justice, and the Trade-marks Opposition Board. Sharon advises clients on intellectual property risk management strategy and intellectual property commercialization strategy. She negotiates and crafts commercial agreements relating to intellectual property including: collaborative research agreements; licenses; assignments; technical consulting and development agreements; technology transfer agreements; material transfer agreements; distribution agreements; non-disclosure and confidentiality agreements; settlement agreement; and escrow agreements.

Sharon’s background, prior to joining MBM, included work with Health Canada developing the legal framework for Canada's new health protection legislation. Sharon is a founding member of MBM's NOC Practice Group. She has built upon her past experience at Health Canada and now advises our clients on issues relating to the Food and Drugs Act and Regulations, the Patented Medicines (Notice of Compliance) Regulations, the Natural Health Product Regulations, and the Patented Medicines Prices Review Board. The range of issues within Sharon's expertise include: the regulatory approval of drugs, medical devices, and natural health products; the Patent List; data protection/exclusivity; and the pricing of patented medicines in Canada.

Education

• B.A., Acadia University
• LL.B., University of New Brunswick

Professional Involvement

• Delta Theta Phi Law Fraternity International
• International Trademark Association (INTA)
• Law Society of Upper Canada (Ontario)
• The Canadian Healthcare Licensing Association (CHLA)